Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752125 · ClinicalTrials.gov registry record · NA
Influence of Flavonoids and Caffeine Supplementation on Resting Metabolism
A NA study of Diet Modification, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT03752125: Completed NA study of Diet Modification, sponsored by Appalachian State University.
NCT03752125 is a NA study of Diet Modification that has completed, run by Appalachian State University. The registered enrollment target is 25 participants, below the 13,239-participant average among 19 other Diet Modification trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03752125, a NA study of Diet Modification, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effect of ingesting caffeine and mixed flavonoids (4 capsules, split between breakfast and lunch) on energy expenditure and fat oxidation in a metabolic chamber with 20 women (non-obese, healthy, ages 20-47 years, pre-menopausal). We hypothesize that based on the existing literature, ingestion of a double dose of the caffeine-mixed flavonoid supplement compared to placebo will increase fat oxidation and increase 24 h energy expenditure by about 75 kilocalories.
Primary Outcome
Energy expenditure (kilocalories) over 24 h in metabolic chamber with oxygen consumption and carbon dioxide production analyzers whereby energy expenditure is calculated from respiratory exchange data (oxygen consumption, carbon dioxide production) using standard equations
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Flavonoid, caffeine
Study Locations (1)
North Carolina
- Appalachian State University Human Performance Lab, North Carolina Research Campus - Kannapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-04-22 |
| Est. Completion | 2019-04-19 |
| Phase | NA |
What the finished NCT03752125 record still lists
NCT03752125 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 13,239-participant average among 19 other Diet Modification trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Diet Modification appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03752125 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03752125 about?
NCT03752125 is a clinical study titled "Influence of Flavonoids and Caffeine Supplementation on Resting Metabolism". The purpose of this study is to compare the effect of ingesting caffeine and mixed flavonoids (4 capsules, split between breakfast and lunch) on energy expenditure and fat oxidation in a metabolic chamber with 20 women (non-obese, healthy, ages 20-47 years, pre-menopausal). We hypothesize that based...
What is the current status of trial NCT03752125?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-04-22. Estimated completion is 2019-04-19.
What conditions does trial NCT03752125 study?
This clinical trial studies the following conditions: Diet Modification.
What interventions are being tested in trial NCT03752125?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Flavonoid, caffeine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03752125?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03752125 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diet Modification
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03752125's enrollment target sits among peer trials
25 16th of 19 higher than 4 of 19 other Diet Modification trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diet Modification trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Regulation of Craving Training (mROC-T) to Improve Dietary Intake in Rural Adolescent Girls
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Fermented Food-Supplemented Diet in Ulcerative Colitis
RECRUITING · NA
-
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
RECRUITING · NA
-
Increasing Lean Protein Intake in Preschool-age Children and Assessing Effects on Cognition and Select Health Outcomes
RECRUITING · NA
-
The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI